205 related articles for article (PubMed ID: 8380129)
41. [Alteration of genomic structure and/or expression of cancer associated genes in hepatocellular carcinoma].
Fujimoto Y; Kohgo Y
Rinsho Byori; 1998 Jan; 46(1):9-14. PubMed ID: 9492532
[TBL] [Abstract][Full Text] [Related]
42. The pathogenesis of hepatocellular carcinoma is multifactorial event. Novel immunological treatment in prospect.
Marotta F; Vangieri B; Cecere A; Gattoni A
Clin Ter; 2004 May; 155(5):187-99. PubMed ID: 15344567
[TBL] [Abstract][Full Text] [Related]
43. Mutations in the p53 tumor suppressor gene in tree shrew hepatocellular carcinoma associated with hepatitis B virus infection and intake of aflatoxin B1.
Park US; Su JJ; Ban KC; Qin L; Lee EH; Lee YI
Gene; 2000 Jun; 251(1):73-80. PubMed ID: 10863098
[TBL] [Abstract][Full Text] [Related]
44. [Universal presence of HBVx gene and its close association with hotspot mutation of p53 gene in hepatocellular carcinoma of prevalent area in China].
Zhang F; Zhu Y; Sun Z
Zhonghua Zhong Liu Za Zhi; 1998 Jan; 20(1):18-21. PubMed ID: 10921048
[TBL] [Abstract][Full Text] [Related]
45. Genetic alterations in hepatocellular carcinomas: association between loss of chromosome 4q and p53 gene mutations.
Rashid A; Wang JS; Qian GS; Lu BX; Hamilton SR; Groopman JD
Br J Cancer; 1999 Apr; 80(1-2):59-66. PubMed ID: 10389978
[TBL] [Abstract][Full Text] [Related]
46. The mouse equivalent of the human p53ser249 mutation p53ser246 enhances aflatoxin hepatocarcinogenesis in hepatitis B surface antigen transgenic and p53 heterozygous null mice.
Ghebranious N; Sell S
Hepatology; 1998 Apr; 27(4):967-73. PubMed ID: 9537435
[TBL] [Abstract][Full Text] [Related]
47. Oltipraz-mediated changes in aflatoxin B(1) biotransformation in rat liver: implications for human chemointervention.
Buetler TM; Bammler TK; Hayes JD; Eaton DL
Cancer Res; 1996 May; 56(10):2306-13. PubMed ID: 8625305
[TBL] [Abstract][Full Text] [Related]
48. Target gene modulation in hepatocellular carcinomas by decreased DNA-binding of p53 mutations.
Kubicka S; Trautwein C; Niehof M; Manns M
Hepatology; 1997 Apr; 25(4):867-73. PubMed ID: 9096590
[TBL] [Abstract][Full Text] [Related]
49. 249ser p53 mutation in the serum of black southern African patients with hepatocellular carcinoma.
Kimbi GC; Kew MC; Yu MC; Arakawa K; Hodkinson J
J Gastroenterol Hepatol; 2005 Aug; 20(8):1185-90. PubMed ID: 16048565
[TBL] [Abstract][Full Text] [Related]
50. TP53 and hepatocellular carcinoma.
Puisieux A; Ozturk M
Pathol Biol (Paris); 1997 Dec; 45(10):864-70. PubMed ID: 9769950
[TBL] [Abstract][Full Text] [Related]
51. ras mutations in 2-acetylaminofluorene-induced lung and liver tumors from C3H/HeJ and (C3H x A/J)F1 mice.
Wang Y; Wang Y; Stoner G; You M
Cancer Res; 1993 Apr; 53(7):1620-4. PubMed ID: 8453632
[TBL] [Abstract][Full Text] [Related]
52. Impacts of chemicals on liver cancer risk.
Wogan GN
Semin Cancer Biol; 2000 Jun; 10(3):201-10. PubMed ID: 10936069
[TBL] [Abstract][Full Text] [Related]
53. The chemistry and biology of aflatoxin B(1): from mutational spectrometry to carcinogenesis.
Smela ME; Currier SS; Bailey EA; Essigmann JM
Carcinogenesis; 2001 Apr; 22(4):535-45. PubMed ID: 11285186
[TBL] [Abstract][Full Text] [Related]
54. Alterations in the structural gene and the expression of p53 in rat liver tumors induced by aflatoxin B1.
Lilleberg SL; Cabonce MA; Raju NR; Wagner LM; Kier LD
Mol Carcinog; 1992; 6(2):159-72. PubMed ID: 1356344
[TBL] [Abstract][Full Text] [Related]
55. Aflatoxin and p53 abnormality in duck hepatocellular carcinoma.
Imazeki F; Yokosuka O; Ohto M; Omata M
J Gastroenterol Hepatol; 1995; 10(6):646-9. PubMed ID: 8580407
[TBL] [Abstract][Full Text] [Related]
56. An aflatoxin-associated mutational hotspot at codon 249 in the p53 tumor suppressor gene occurs in hepatocellular carcinomas from Mexico.
Soini Y; Chia SC; Bennett WP; Groopman JD; Wang JS; DeBenedetti VM; Cawley H; Welsh JA; Hansen C; Bergasa NV; Jones EA; DiBisceglie AM; Trivers GE; Sandoval CA; Calderon IE; Munoz Espinosa LE; Harris CC
Carcinogenesis; 1996 May; 17(5):1007-12. PubMed ID: 8640905
[TBL] [Abstract][Full Text] [Related]
57. Allele-specific PCR analysis of p53 codon 249 AGT transversion in liver tissues from patients with viral hepatitis.
Kirby GM; Batist G; Fotouhi-Ardakani N; Nakazawa H; Yamasaki H; Kew M; Cameron RG; Alaoui-Jamali MA
Int J Cancer; 1996 Sep; 68(1):21-5. PubMed ID: 8895534
[TBL] [Abstract][Full Text] [Related]
58. In vitro recapitulating of TP53 mutagenesis in hepatocellular carcinoma associated with dietary aflatoxin B1 exposure.
Besaratinia A; Kim SI; Hainaut P; Pfeifer GP
Gastroenterology; 2009 Sep; 137(3):1127-37, 1137.e1-5. PubMed ID: 19524575
[TBL] [Abstract][Full Text] [Related]
59. The lectin-binding characteristics of aflatoxin B1 induced lesions in the rat liver.
Pritchard DJ; Butler WH
J Pathol; 1988 Mar; 154(3):269-76. PubMed ID: 3127568
[TBL] [Abstract][Full Text] [Related]
60. Selective targeting of p53 gene mutational hotspots in human cancers by etiologically defined carcinogens.
Puisieux A; Lim S; Groopman J; Ozturk M
Cancer Res; 1991 Nov; 51(22):6185-9. PubMed ID: 1933877
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
